Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
The earnings call highlights a positive outlook with record-high subscription revenue, improved gross margins, and strong international growth. Despite increased expenses, the company shows a strategic focus on high ROI initiatives and profitable growth. While operating losses widened, the adjusted EBITDA was at the higher end of guidance. The Q&A session provided clarity on cost management and strategic focus areas, with a strong emphasis on subscription and international expansion. Overall, the positive financial performance and strategic direction suggest a likely positive stock price movement in the short term.
Q1 Total Revenue $22.5 million, up 6.4% year-over-year. The increase was despite a one-time inventory rightsizing at a large retail partner, which negatively impacted sell-in revenue.
Subscription Revenue $2.7 million in Q1, a record high, with a gross margin of 67.4%. This reflects sequential growth and highlights the success of the subscription model.
Overall Gross Margin 54.5% in Q1, up 80 basis points year-over-year. This includes a 480 basis point impact from the cost of tariffs.
Total Operating Expenses $17.7 million in Q1, compared to $14 million in the prior year. The increase was primarily driven by higher compensation costs, including stock-based compensation, and the impact of headcount additions.
Operating Loss $5.5 million in Q1, compared to $2.7 million in the same period last year. This reflects increased operating expenses.
Net Loss $3.3 million in Q1, reflecting the overall financial performance and increased expenses.
Adjusted EBITDA Negative $1.5 million in Q1, at the high end of the guidance range of negative $2.5 million to $1.5 million. The decline was primarily due to tariff cost impacts.
Cash and Cash Equivalents $35.5 million as of March 31, 2026, in line with the fourth quarter of 2025. Total liquidity, including undrawn credit, was $39.4 million.
International Revenue Grew 22% year-over-year in Q1, with sell-through showing 37% year-over-year growth. This reflects strong momentum in international markets.
Domestic Sell-Through Units for Sock and Duo Grew 10.5% year-over-year in Q1, led by a 45% increase in Duo and a 3% increase in Dream Sock. Owlet dollars grew 11% while the overall baby monitoring category declined 19%.
Monthly Recurring Revenue (MRR) $1 million at the end of Q1, highlighting the compounding value of the subscriber base.
Owlet360 Subscription and Telehealth: Owlet is prioritizing the Owlet360 subscription and telehealth opportunity, aiming to convert one-time users into 4-year subscribers. New features and AI integrations for Dream Sock and camera subscription features are being launched to enhance value. International expansion of subscriptions is also planned.
Dream Sock and Duo: Domestic sell-through units for Sock and Duo grew 10.5% year-over-year, with Duo increasing by 45% and Dream Sock by 3%. Owlet was the only brand in the category to grow during a general market decline.
Owlet OnCall Telehealth: Owlet OnCall telehealth is being launched, allowing parents to communicate directly with pediatricians via the app. This initiative is expected to provide deeper value to parents and create a new revenue stream.
Core Market Focus: Owlet is focusing on high-value opportunities in existing core markets, deferring planned entries into India, Hong Kong, and Singapore. U.S. market penetration is at 11%, with significant growth potential in Europe and other regions.
International Growth: International revenue grew 22% year-over-year in Q1, with strong sell-through in markets like the Czech Republic, U.K., Germany, France, and Australia. Europe presents a massive growth opportunity due to higher birth rates.
Operational Efficiency: Owlet is pausing new global clearances, delaying country launches, and eliminating planned headcount additions to optimize spending and drive profitable growth. Lower ROI projects outside the core 0-24 month segment are being deferred.
Financial Discipline: Revenue guidance for 2026 has been adjusted to $118-$122 million, focusing on high-margin opportunities. Adjusted EBITDA guidance has been raised to $7-$9 million, representing 250%-350% growth year-over-year.
Subscription-First Approach: Owlet is transitioning from hardware-centric sales to a subscription-first model, aligning product roadmaps, marketing, and partnerships to increase subscription penetration.
AI and Data-Driven Pediatric Health: Owlet is leveraging its pediatric health data set, FDA-cleared hardware, and parent relationships to deliver personalized infant care and establish itself as a leading pediatric health platform.
Leadership Transition: The recent leadership transition, with Kurt Workman stepping back into the CEO role, could pose challenges in maintaining continuity and stability during a critical growth phase.
Subscription Model Shift: The shift from a hardware-centric sales model to a subscription-first approach requires significant execution focus and could face challenges in customer adoption and retention.
Geographic Expansion Delays: Planned entries into India, Hong Kong, and Singapore have been deferred, potentially limiting growth opportunities in these high-potential markets.
Operational Efficiency Measures: Pausing new global clearances, delaying country launches, and eliminating planned headcount additions could strain resources and impact the ability to scale efficiently.
Revenue Guidance Adjustment: Revenue guidance for 2026 has been revised downward, reflecting a deliberate exit from lower-margin revenue streams and a more conservative sell-through outlook, which could impact overall growth.
Tariff Costs: Tariff costs continue to impact gross margins, with a 15% tariff rate estimated for the remainder of the year, creating financial pressure.
Inventory Rightsizing: A one-time inventory rightsizing at a large retail partner negatively impacted Q1 sell-in revenue, highlighting potential vulnerabilities in retail partnerships.
Owlet360 subscription and telehealth opportunity: Owlet is prioritizing the Owlet360 subscription and telehealth opportunity, aiming to convert its established user base into long-term subscribers. The company plans to launch new features and AI integrations for Dream Sock, introduce new camera subscription features, and expand subscription access internationally. This shift from hardware-centric sales to a multiyear subscription model is expected to transform the business profile and strengthen Owlet's role in pediatric health.
Focus on core markets: Owlet is concentrating on high-value opportunities within its existing core markets, particularly in the U.S. and Europe, where there is significant growth potential. The company is deferring planned entries into India, Hong Kong, and Singapore to focus on established markets with higher near-term return potential.
Operational efficiency and financial discipline: Owlet is emphasizing operational efficiency and financial discipline to drive profitable growth. This includes pausing new global clearances, delaying country launches, eliminating planned headcount additions, and deferring lower ROI projects. The goal is to align the cost structure to scale efficiently and reinvest strategically.
Revenue guidance for 2026: Owlet has updated its full-year 2026 revenue guidance to a range of $118 million to $122 million, representing 12% to 15% year-over-year growth. This adjustment reflects the decision to exit lower-margin revenue streams in noncore geographies and adopt a more conservative view on sell-through for the remainder of the year.
Adjusted EBITDA guidance for 2026: The company has raised its full-year 2026 adjusted EBITDA guidance to a range of $7 million to $9 million, representing 250% to 350% growth year-over-year. This increase is attributed to a disciplined approach to profitability and operational efficiency.
Gross margin expectations for 2026: Owlet expects gross margins in the range of 50% to 52% for the full year 2026, with a dynamic tariff situation being closely monitored.
The selected topic was not discussed during the call.
The earnings call highlights a positive outlook with record-high subscription revenue, improved gross margins, and strong international growth. Despite increased expenses, the company shows a strategic focus on high ROI initiatives and profitable growth. While operating losses widened, the adjusted EBITDA was at the higher end of guidance. The Q&A session provided clarity on cost management and strategic focus areas, with a strong emphasis on subscription and international expansion. Overall, the positive financial performance and strategic direction suggest a likely positive stock price movement in the short term.
The earnings call indicates strong financial performance with a 14.3% increase in FFO, reduced leverage, and strategic acquisitions. Management's focus on expanding in key markets and maintaining stable leasing spreads adds to the positive outlook. Although some responses were vague, the overall sentiment and financial metrics suggest a positive impact on stock price.
The earnings call highlights strong revenue growth, record high gross margins, and improved EBITDA, indicating operational efficiency. Positive sentiments arise from planned AI-driven product enhancements and international expansion. Although Q1 guidance is lower due to seasonality, the full-year outlook remains robust. The Q&A session reveals optimism in subscription growth and international expansion, despite management's reluctance to provide specific churn metrics. Given these factors, the stock price is likely to experience a positive movement, driven by strong financial performance and strategic growth initiatives.
The earnings call highlights strong financial performance with record revenue and profit, despite tariff challenges. Positive guidance and strategic initiatives, such as international expansion and healthcare partnerships, bolster growth prospects. The Q&A reveals confidence in ongoing partnerships and market expansion, though some details, like subscriber retention, remain vague. Overall, the strong earnings and optimistic guidance, coupled with strategic partnerships, suggest a positive stock price movement.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.